Corporate News

CNSL (AIM: CNSL), the specialist medical diagnostics company focused on delivering a personalised approach to nutrition for better health, announces its audited results for the year ended 31 March 2025, a year that has seen the establishment of a robust foundation for the future after transitioning out of a diverse group structure.

Financial highlights

• > Total Income up 12.7% to £11.1m (2024 | £9.9m)
• > Revenues down -14.8% to £8.3m (2024| £9.8m)
• > Gross margin rose by 5.5% to 65.3% (2024 | 61.9%)
• > Adjusted EBITDA* grew by 115.4% to £0.4m (2024 | adjusted EBITDA £0.2m)
• > Profit before taxation grew by 310% to £1.6m
  (2024: -£0.7m loss (Stated after net exceptional income of £1.8m (2024: costs of £0.2m)
• > Cash and deposits fell by -10.6% to £4.9m (2024: £5.4m)

Operational highlights

• > CNSLab productivity CNSLab productivity improvements have increased capacity and halved guaranteed turnaround times to customers
• > Scrap yields Improved production yields have led to a reduction in scrap by 41%
• > Automation Investment in automation to further improve productivity and reduce production costs
• > UK lab sales UK lab sales increased by 9% driven by increased consumer demand through white label partnerships
• > MyHealthTracker App UK deployment of MyHealthTracker digital app to practitioner base
• > Funding Well funded to drive future growth
• > New leadership team Now at full complement enabling future growth

*Adjusted for exceptional items and share based payment charges.

Carolyn Rand, Chair of CNSL, comments “I am very pleased to report that the last 12 months have delivered significant progress and achievement across the business. The impact of our new leadership team and the progress made by the rest of the business is evident in the successful resolution of all outstanding historical legal cases and a significant growth in adjusted EBITDA.

Continuous improvements to our gross margin driven by our focus on operational improvements and a targeted sales strategy, reflect the teams’ tireless commitment and the underlying strength of the business. We have established a capable and forward-looking Board and leadership team, which supported by the investment in structures, systems, and processes, positions the company well for future long-term success."

Contacts

Cambridge Nutritional Sciences plc | cnspl.com | [email protected]
James Cooper | Chief Executive Officer
Ajay Patel | Chief Financial Officer  

Cavendish Capital Markets Ltd | Geoff Nash / Edward Whiley (Corporate Finance)
Nigel Birks / Harriet Ward (ECM) | 020 7220 0500

About Cambridge Nutritional Sciences plc

Cambridge Nutritional Sciences plc (AIM: CNSL) is the specialist medical diagnostics company focused on delivering a personalised approach to nutrition for better health.